Halberd Corp
OTC:HALB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BAE Systems PLC
LSE:BA
|
UK |
|
Yuma Energy Inc
OTC:YUMAQ
|
US |
Halberd Corp
Total Current Liabilities
Halberd Corp
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Halberd Corp
OTC:HALB
|
Total Current Liabilities
$1.3m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Current Liabilities
$25.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
17%
|
CAGR 10-Years
11%
|
|
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Total Current Liabilities
$1.5B
|
CAGR 3-Years
24%
|
CAGR 5-Years
20%
|
CAGR 10-Years
37%
|
|
|
Revolution Medicines Inc
NASDAQ:RVMD
|
Total Current Liabilities
$290.4m
|
CAGR 3-Years
67%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
|
United Therapeutics Corp
NASDAQ:UTHR
|
Total Current Liabilities
$560.6m
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
2%
|
|
|
Moderna Inc
NASDAQ:MRNA
|
Total Current Liabilities
$2B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Halberd Corp
Glance View
Halberd Corp. is a development stage company, researches and develops antibodies and devices for the prevention, detection, and treatment of Covid-19 through laboratory, hospital, and clinical trials. The company is headquartered in Jackson Center, Pennsylvania. The company went IPO on 2009-06-12. The firm is a research-based company that intends to discover and develop medical treatments for a range of diseases. The firm's extracorporeal treatment is applicable for hard-to-cure blood-borne and neurologic diseases, such as post-traumatic stress disorder (PTSD) and Alzheimer's disease. The company is also developing treatment for coronavirus disease of 2019 (Covid-19), obesity, such as high blood pressure, diabetes, heart disease, stroke, and cancer.
See Also
What is Halberd Corp's Total Current Liabilities?
Total Current Liabilities
1.3m
USD
Based on the financial report for Jul 31, 2012, Halberd Corp's Total Current Liabilities amounts to 1.3m USD.
What is Halberd Corp's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 3Y
22%
Over the last year, the Total Current Liabilities growth was 138%. The average annual Total Current Liabilities growth rates for Halberd Corp have been 22% over the past three years .
